Results 11 to 20 of about 187,919 (323)
BMC Medicine, 2020 Background Beta-blockers are widely used for many cardiovascular conditions; however, their efficacy in contemporary clinical practice remains uncertain.
Oliver J. Ziff +6 more
doaj +1 more source
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure. [PDF]
, 2019 BACKGROUND: Moderate and moderately severe renal impairment are common in patients with heart failure and reduced ejection fraction, but whether beta-blockers are effective is unclear, leading to underuse of life-saving therapy.
Andersson, B +22 more
core +8 more sources
Beta-blockers in COPD:time for reappraisal [PDF]
, 2016 The combined effects on the heart of smoking and hypoxaemia may contribute to an increased cardiovascular burden in chronic obstructive pulmonary disease (COPD).
Devereux, Graham +4 more
core +3 more sources
Die Beta-Adrenerge blokkeermiddels
South African Family Practice, 1980 No abstract available.
Loubie Walters
doaj +1 more source
Beta blockers in traumatic brain injury: a systematic review and meta-analysis
Trauma Surgery & Acute Care Open, 2023 Background Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Beta blockers have shown promise in improving mortality and functional outcomes after TBI. The aim of this article is to synthesize the available clinical data on
Andrew Chen +5 more
doaj +1 more source
ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker [PDF]
, 2016 Novel action beta-blockers combine many different pharmacological effects. The espindolol exhibits effects through β and central 5-HT1α receptors to demonstrate pro-anabolic, anti-catabolic, and appetite-stimulating actions.
Lainscak, Mitja, LAVIANO, Alessandro
core +1 more source
Correlation between prescribing quality and pharmaceutical costs in English primary care: national cross-sectional analysis [PDF]
, 2011 Background Both pharmaceutical costs and quality-indicator performance vary substantially between general practices, but little is known about the relationship between prescribing costs and quality Aim To measure the association between prescribing ...
Allsup +8 more
core +1 more source
Journal of Pharmacoeconomics and Pharmaceutical Management, 2021 Background: Beta-blockers are preferred anti-hypertensive for patients with compelling indications. Vasodilator beta-blockers are of particular benefit in blood pressure control and other cardio-metabolic components with limited disturbance in metabolic
Mende Mensa Sorato +2 more
doaj
Inappropriate use of beta-blockers among medical and dental students at King Saud University, Riyadh
Journal of Family Medicine and Primary Care, 2020 Aim: Self-medication and inappropriate beta-blocker use have been commonly reported among students. This study aimed to determine the prevalence of inappropriate self-prescription of beta-blockers among medical and dental students.
Abdulelah Adnan Abukhalaf +6 more
doaj +1 more source
BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
Рациональная фармакотерапия в кардиологии, 2015 Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj +3 more sources